David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Global Class C
LBTYK
|
+$404M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$361M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$327M |
| 4 |
Procter & Gamble
PG
|
+$313M |
| 5 |
Netflix
NFLX
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Bank of America
BAC
|
+$405M |
| 3 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$236M |
| 4 |
Citigroup
C
|
+$219M |
| 5 |
SLB Ltd
SLB
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 9.3% |
| 2 | Healthcare | 8.21% |
| 3 | Consumer Discretionary | 8.05% |
| 4 | Energy | 7.7% |
| 5 | Technology | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
EQT Corp
EQT
$33.6B
| $92.5M | 0.13% |
1,752,226
+741,224
| +73% | +$38.6M |
|
|
AGN
152
DELISTED
Allergan Inc
AGN
| $92.5M | 0.13% |
745,203
+533,015
| +251% | +$64.9M |
|
|
HSH
153
DELISTED
HILLSHIRE BRANDS CO
HSH
| $92.4M | 0.13% |
2,480,346
-21,976
| -0.9% | -$788K |
|
|
CLGX
154
DELISTED
Corelogic, Inc.
CLGX
| $91.7M | 0.13% |
3,053,248
+538,582
| +21% | +$17.7M |
|
|
SNDK
155
DELISTED
SANDISK CORP
SNDK
| $91.7M | 0.13% |
1,129,475
+865,405
| +328% | +$63.9M |
|
|
HNT
156
DELISTED
HEALTH NET INC
HNT
| $91.7M | 0.13% |
2,694,865
-718,182
| -21% | -$23.6M |
|
157
Adobe
ADBE
$109B
| $91.3M | 0.13% |
1,388,904
-156,248
| -10% | -$10M |
|
158
Simon Property Group
SPG
$70.6B
| $91.1M | 0.13% |
590,425
-119,699
| -17% | -$17.8M |
|
|
CELG
159
PUT
DELISTED
Celgene Corp
CELG
| $90.9M | 0.13% |
1,303,000
-258,200
| -17% | -$20.4M |
|
|
GRA
160
DELISTED
W.R. Grace & Co.
GRA
| $89.7M | 0.13% |
904,291
+298,043
| +49% | +$29.3M |
|
161
CALL
Johnson & Johnson
JNJ
$651B
| $89.4M | 0.13% |
910,500
| – | – |
|
162
Amazon
AMZN
$2.79T
| $89M | 0.13% |
5,291,380
-4,130,920
| -44% | -$76.7M |
|
163
Ford
F
$57.5B
| $88.5M | 0.13% |
5,675,552
-2,715,022
| -32% | -$42M |
|
|
KRFT
164
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $87.3M | 0.12% |
1,556,881
-340,460
| -18% | -$18.5M |
|
165
PUT
Starbucks
SBUX
$122B
| $87.1M | 0.12% |
2,373,400
-1,301,000
| -35% | -$48.1M |
|
166
CALL
ExxonMobil
XOM
$679B
| $86.3M | 0.12% |
883,100
+379,200
| +75% | +$36.1M |
|
167
Equity Lifestyle Properties
ELS
$12.7B
| $86.1M | 0.12% |
4,234,716
-229,056
| -5% | -$4.49M |
|
168
PUT
JPMorgan Chase
JPM
$935B
| $85.9M | 0.12% |
1,415,200
-775,400
| -35% | -$44.8M |
|
169
Omnicom Group
OMC
$24B
| $85.8M | 0.12% |
1,182,241
-114,665
| -9% | -$8.43M |
|
|
WBA
170
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $85.5M | 0.12% |
1,295,500
+177,500
| +16% | +$11.2M |
|
|
WNR
171
DELISTED
Western Refining Inc
WNR
| $85.2M | 0.12% |
2,207,932
+619,237
| +39% | +$24.3M |
|
172
NewMarket
NEU
$8.62B
| $85.1M | 0.12% |
217,815
+13,764
| +7% | +$4.88M |
|
173
Freeport-McMoran
FCX
$110B
| $84.9M | 0.12% |
2,568,612
-822,896
| -24% | -$27.4M |
|
174
Teva Pharmaceuticals
TEVA
$43.5B
| $84.6M | 0.12% |
1,601,875
+1,096,366
| +217% | +$50.7M |
|
|
VMRK
175
Vivmark Residential
VMRK
$25B
| $84.3M | 0.12% |
1,452,833
-812,928
| -36% | -$45.9M |
|
Similar funds
David Shaw's Q1 2014 Portfolio in Review
As of Q1 2014, David Shaw held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $4.59B in Q1 2014, closing 795 positions and reducing 1,925 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $236M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 9.3% of assets, up from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Veren worth $53.3M.
- David Shaw's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
- David Shaw added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
- David Shaw's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
- David Shaw fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
- David Shaw's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
- David Shaw opened 596 new positions and closed 795 in Q1 2014.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $70.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.